Work

Forodesine IV (Bcx-1777) Is Clinically Active in Relapsed/Refractory T-Cell Leukemia: Results of a Phase II Study (Interim Report).

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.1851.1851

Authors: Richard R. Furman, Lia Gore, Farhad Ravandi, Dieter Hoelzer

Institutions: Cornell University, Weill Cornell Medicine, The University of Texas MD Anderson Cancer Center, Goethe University Frankfurt, University Hospital Frankfurt

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590777883

FWCI: 2.663

Cites:

Cited by: 28

Related to: 10